| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Atkinson D et al. | Sphingosine 1-phosphate lyase deficiency causes Charcot-Marie-Tooth neuropathy. | 2017 | Neurology | pmid:28077491 |
| Verhoeven K et al. | SPTLC1 mutation in twin sisters with hereditary sensory neuropathy type I. | 2004 | Neurology | pmid:15037712 |
| Goldman MD and Naismith RT | Multiple sclerosis, immunomodulation, and immunizations: balancing the benefits. | 2015 | Neurology | pmid:25636716 |
| Kowarik MC et al. | Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS. | 2011 | Neurology | pmid:21464424 |
| Uccelli A et al. | Primary varicella zoster infection associated with fingolimod treatment. | 2011 | Neurology | pmid:21403115 |
| Warnke C et al. | Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia. | 2014 | Neurology | pmid:25361781 |
| Antel J and Hohlfeld R | Modulation of sphingosine 1-phosphate signaling in neurologic disease. | 2011 | Neurology | pmid:21360856 |
| Slavin AJ and Zamvil SS | FTY720 and central memory: out of sight, out of mind. | 2010 | Neurology | pmid:20610831 |
| Schwarz A et al. | Critical vasospasm during fingolimod (FTY720) treatment in a patient with multiple sclerosis. | 2010 | Neurology | pmid:20548047 |
| Giovannoni G and Naismith RT | Natalizumab to fingolimod washout in patients at risk of PML: when good intentions yield bad outcomes. | 2014 | Neurology | pmid:24610331 |
| Jokubaitis VG et al. | Fingolimod after natalizumab and the risk of short-term relapse. | 2014 | Neurology | pmid:24610329 |
| Rolf L et al. | Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment. | 2014 | Neurology | pmid:24523479 |
| Jain N and Bhatti MT | Fingolimod-associated macular edema: incidence, detection, and management. | 2012 | Neurology | pmid:22371414 |
| Henault D et al. | Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis. | 2013 | Neurology | pmid:24132373 |
| Wattjes MP et al. | Author response. | 2013 | Neurology | pmid:24044116 |
| Schneider JS and DiStefano L | Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism. | 1994 | Neurology | pmid:8164837 |
| Kappos L et al. | Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS. | 2015 | Neurology | pmid:26024899 |
| Stüve O and Bourdette D | Natalizumab to fingolimod: Questions answered, unanswered, and unasked. | 2015 | Neurology | pmid:26024898 |
| Kinney MO and McDonnell G | Re: Tumefactive multiple sclerosis lesions under fingolimod treatment. | 2013 | Neurology | pmid:23877798 |
| McNamara PH et al. | Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod. | 2013 | Neurology | pmid:23858414 |
| Tully T et al. | Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod. | 2015 | Neurology | pmid:25878178 |
| Bielekova B and McDermott MP | Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis? | 2015 | Neurology | pmid:25809305 |
| Kuhle J et al. | Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis. | 2015 | Neurology | pmid:25809304 |
| Ricklin ME et al. | T-cell response against varicella-zoster virus in fingolimod-treated MS patients. | 2013 | Neurology | pmid:23700335 |
| Kappos L et al. | Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trial. | 2015 | Neurology | pmid:25795646 |
| Acharya JK et al. | Cell-nonautonomous function of ceramidase in photoreceptor homeostasis. | 2008 | Neuron | pmid:18184565 |
| Cline HT and Constantine-Paton M | The differential influence of protein kinase inhibitors on retinal arbor morphology and eye-specific stripes in the frog retinotectal system. | 1990 | Neuron | pmid:2361013 |
| Bixby JL | Protein kinase C is involved in laminin stimulation of neurite outgrowth. | 1989 | Neuron | pmid:2561968 |
| Darios F et al. | Sphingosine facilitates SNARE complex assembly and activates synaptic vesicle exocytosis. | 2009 | Neuron | pmid:19524527 |
| Zhang Z et al. | Early attenuation of lesional interleukin-16 up-regulation by dexamethasone and FTY720 in experimental traumatic brain injury. | 2008 | Neuropathol. Appl. Neurobiol. | pmid:17983426 |
| Zhang ZY et al. | FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis. | 2009 | Neuropathol. Appl. Neurobiol. | pmid:19207263 |
| O'Sullivan S and Dev KK | Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases. | 2017 | Neuropharmacology | pmid:27825807 |
| Pan CY et al. | Lysophospholipids elevate [Ca2+]i and trigger exocytosis in bovine chromaffin cells. | 2006 | Neuropharmacology | pmid:16616768 |
| Osinde M et al. | Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. | 2007 | Neuropharmacology | pmid:17379261 |
| Pierucci F et al. | Vitamin D protects against Aβ peptide cytotoxicity in differentiated human neuroblastoma SH- SY5Y cells: A role for S1P1/p38MAPK/ATF4 axis. | 2017 | Neuropharmacology | pmid:28077289 |
| Imeri F et al. | Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice. | 2014 | Neuropharmacology | pmid:24863045 |
| Pollock J et al. | TNF-alpha receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurones. | 2002 | Neuropharmacology | pmid:11750919 |
| Schneider JS and Distefano L | Response of the damaged dopamine system to GM1 and semisynthetic gangliosides: effects of dose and extent of lesion. | 1995 | Neuropharmacology | pmid:7566482 |
| Anthony DC et al. | Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model. | 2014 | Neuropharmacology | pmid:24412675 |
| Güntert T et al. | 1-Deoxysphingolipid-induced neurotoxicity involves N-methyl-d-aspartate receptor signaling. | 2016 | Neuropharmacology | pmid:27016021 |
| Lim ST et al. | Exogenous gangliosides increase the release of brain-derived neurotrophic factor. | 2011 | Neuropharmacology | pmid:20971126 |
| Callihan P et al. | Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cells. | 2012 | Neuropharmacology | pmid:22016110 |
| Masgrau R et al. | BM88/Cend1 regulates stimuli-induced intracellular calcium mobilization. | 2009 | Neuropharmacology | pmid:19061903 |
| Lipartiti M et al. | Ganglioside derivative LIGA20 reduces NMDA neurotoxicity in neonatal rat brain. | 1992 | Neuroreport | pmid:1421099 |
| Jiang Q et al. | Nuclear translocation of extracellular signal-regulated kinases in neuronal excitotoxicity. | 2001 | Neuroreport | pmid:11496121 |
| Ramos B et al. | Inhibition of phosphatidylcholine synthesis precedes apoptosis induced by C2-ceramide: protection by exogenous phosphatidylcholine. | 2000 | Neuroreport | pmid:11043531 |
| McGuinness N et al. | The effects of trans-ACPD on long-term potentiation in the rat hippocampal slice. | 1991 | Neuroreport | pmid:1667272 |
| Centeno F et al. | Partial lithium-associated protection against apoptosis induced by C2-ceramide in cerebellar granule neurons. | 1998 | Neuroreport | pmid:9926873 |
| Schneider JS and DiStefano L | LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment. | 1993 | Neuroreport | pmid:8110995 |
| Arboleda G et al. | Inhibition of caspases but not of calpains temporarily protect against C2-ceramide-induced death of CAD cells. | 2007 | Neurosci. Lett. | pmid:17573191 |
| Tamai Y et al. | Creutzfeldt-Jakob disease--alteration in ganglioside sphingosine in the brain of a patient. | 1979 | Neurosci. Lett. | pmid:372860 |
| Agudo-López A et al. | Involvement of mitochondria on neuroprotective effect of sphingosine-1-phosphate in cell death in an in vitro model of brain ischemia. | 2010 | Neurosci. Lett. | pmid:20045720 |
| Muñoz-Sáez E et al. | Neuroprotective role of sphingosine-1-phosphate in L-BMAA treated neuroblastoma cells (SH-SY5Y). | 2015 | Neurosci. Lett. | pmid:25769802 |
| Nishimura B et al. | The influences of sphingolipid metabolites on gentamicin-induced hair cell loss of the rat cochlea. | 2010 | Neurosci. Lett. | pmid:20709153 |
| Boiron-Sargueil F et al. | Cerebroside formation in the peripheral nervous system of normal and Trembler mice. | 1995 | Neurosci. Lett. | pmid:7783943 |
| Jaramillo-Gómez J et al. | Overexpression of DJ-1 protects against C2-ceramide-induced neuronal death through activation of the PI3K/AKT pathway and inhibition of autophagy. | 2015 | Neurosci. Lett. | pmid:26222260 |
| Matsumoto M and Barnard EA | Effects of an activator and an inhibitor of protein kinase C on serotonin receptors induced by rat brain mRNA in Xenopus oocytes. | 1994 | Neurosci. Lett. | pmid:8177520 |
| Jatana M et al. | Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine. | 2002 | Neurosci. Lett. | pmid:12231442 |
| Craighead M et al. | Caspases mediate C2-ceramide-induced apoptosis of the human oligodendroglial cell line, MO3.13. | 2000 | Neurosci. Lett. | pmid:10653009 |
| Tavarini S et al. | Sphingomyelinase metabolites control survival and apoptotic death in SH-SY5Y neuroblastoma cells. | 2000 | Neurosci. Lett. | pmid:10806317 |
| Fan C et al. | Autophagy inhibits C2-ceramide-mediated cell death by decreasing the reactive oxygen species levels in SH-SY5Y cells. | 2017 | Neurosci. Lett. | pmid:28288862 |
| Stessin AM et al. | FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells. | 2012 | Neurosci. Lett. | pmid:22507238 |
| Zheng T et al. | C2-ceramide attenuates prostaglandin F2alpha-induced vasoconstriction and elevation of [Ca2+]i in canine cerebral vascular smooth muscle. | 1998 | Neurosci. Lett. | pmid:9853716 |
| Kułakowska A et al. | Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis. | 2010 | Neurosci. Lett. | pmid:20434523 |
| Boneh A et al. | Effect of sphingosine on rat glial cells: inhibition of prostaglandin E2 and insensitivity of nitric oxide generation. | 1997 | Neurosci. Lett. | pmid:9237488 |
| Doyle T et al. | Sphingosine-1-phosphate acting via the S1Pâ‚ receptor is a downstream signaling pathway in ceramide-induced hyperalgesia. | 2011 | Neurosci. Lett. | pmid:21605625 |
| Esche M et al. | Signalling of sphingosine-1-phosphate in Müller glial cells via the S1P/EDG-family of G-protein-coupled receptors. | 2010 | Neurosci. Lett. | pmid:20540988 |
| Yang MS et al. | Sphingomyelinase but not ceramide induces nitric oxide synthase expression in rat brain microglia. | 2001 | Neurosci. Lett. | pmid:11567796 |
| Calcerrada MC et al. | Sphingosylphosphorylcholine increases calcium concentration in isolated brain nuclei. | 1999 | Neurosci. Res. | pmid:10211767 |
| Storchak LG et al. | Differential effect of protein kinase inhibitors on calcium-dependent and calcium-independent [14C]GABA release from rat brain synaptosomes. | 1998 | Neuroscience | pmid:9639290 |
| Nayak D et al. | Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. | 2010 | Neuroscience | pmid:20036321 |
| Sivasubramanian M et al. | Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ -treated MN9D cells in vitro. | 2015 | Neuroscience | pmid:25637806 |
| Tabarean IV et al. | Interleukin-1beta induces hyperpolarization and modulates synaptic inhibition in preoptic and anterior hypothalamic neurons. | 2006 | Neuroscience | pmid:16777343 |
| Son H and Carpenter DO | Protein kinase C activation is necessary but not sufficient for induction of long-term potentiation at the synapse of mossy fiber-CA3 in the rat hippocampus. | 1996 | Neuroscience | pmid:8730701 |
| Moore AN et al. | Sphingosine-1-phosphate induces apoptosis of cultured hippocampal neurons that requires protein phosphatases and activator protein-1 complexes. | 1999 | Neuroscience | pmid:10579204 |
| Khodorova A et al. | The TrkA receptor mediates experimental thermal hyperalgesia produced by nerve growth factor: Modulation by the p75 neurotrophin receptor. | 2017 | Neuroscience | pmid:27826102 |
| Willaime-Morawek S et al. | C-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis. | 2003 | Neuroscience | pmid:12770554 |
| Vitale ML et al. | Protein kinase C activation by phorbol esters induces chromaffin cell cortical filamentous actin disassembly and increases the initial rate of exocytosis in response to nicotinic receptor stimulation. | 1992 | Neuroscience | pmid:1281530 |
| Wadman WJ and Connor JA | Persisting modification of dendritic calcium influx by excitatory amino acid stimulation in isolated Ca1 neurons. | 1992 | Neuroscience | pmid:1351266 |
| Kanno T et al. | Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus. | 2010 | Neuroscience | pmid:20950672 |
| Schilling T et al. | Lysophospholipids induce membrane hyperpolarization in microglia by activation of IKCa1 Ca(2+)-dependent K(+) channels. | 2002 | Neuroscience | pmid:11927165 |
| Chen YJ et al. | Inflammation triggers production of dimethylsphingosine from oligodendrocytes. | 2014 | Neuroscience | pmid:25151189 |
| Lin N and Friedlander RM | T-cell activation in ischemic stroke: a new therapeutic target for delayed infarct expansion? | 2009 | Neurosurgery | pmid:19934952 |
| Tani K et al. | Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea. | 2016 | Neurotox Res | pmid:26472207 |
| Kwon OS et al. | Biochemical and morphological effects of fumonisin B(1) on primary cultures of rat cerebrum. | 2000 Jul-Aug | Neurotoxicol Teratol | pmid:10974595 |
| Kwon OS et al. | Effects of fumonisin B1 treatment on blood-brain barrier transfer in developing rats. | 1997 Mar-Apr | Neurotoxicol Teratol | pmid:9136132 |
| Rojas-Charry L et al. | Downregulation of Pink1 influences mitochondrial fusion-fission machinery and sensitizes to neurotoxins in dopaminergic cells. | 2014 | Neurotoxicology | pmid:24792327 |
| Arboleda G et al. | Differential regulation of AKT, MAPK and GSK3β during C2-ceramide-induced neuronal death. | 2010 | Neurotoxicology | pmid:20696185 |
| Saucedo-GarcÃa M et al. | MPK6, sphinganine and the LCB2a gene from serine palmitoyltransferase are required in the signaling pathway that mediates cell death induced by long chain bases in Arabidopsis. | 2011 | New Phytol. | pmid:21534970 |
| Michaelson LV | New insights into cell death induced by long chain bases in Arabidopsis. | 2011 | New Phytol. | pmid:21834911 |
| Islam MN et al. | Sphingosine in plants--more riddles from the Sphinx? | 2012 | New Phytol. | pmid:22070536 |
| Ternes P et al. | Disruption of the ceramide synthase LOH1 causes spontaneous cell death in Arabidopsis thaliana. | 2011 | New Phytol. | pmid:21883234 |
| Lynch DV | Evidence that sphingolipid signaling is involved in responding to low temperature. | 2012 | New Phytol. | pmid:22364118 |
| Dutilleul C et al. | Phytosphingosine-phosphate is a signal for AtMPK6 activation and Arabidopsis response to chilling. | 2012 | New Phytol. | pmid:22236066 |
| Chiba K | [A new therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)]. | 2009 | Nihon Rinsho Meneki Gakkai Kaishi | pmid:19404007 |
| Fujii T and Watanabe M | [An additional role of FTY720 in chronic colitis]. | 2009 | Nihon Rinsho Meneki Gakkai Kaishi | pmid:19252372 |
| Hirafuji M et al. | [Modulation of sphingosine 1-phosphate, a new lipid mediator, on nitric oxide production by vascular smooth muscle cells]. | 2002 | Nippon Yakurigaku Zasshi | pmid:12491784 |
| Muraki K et al. | [Effects of sphingosine-1-phosphate, a lipid mediator, in cardiovascular tissues]. | 2002 | Nippon Yakurigaku Zasshi | pmid:12491795 |
| Chiba K and Yoshii N | [Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis]. | 2012 | Nippon Yakurigaku Zasshi | pmid:22728990 |
| Kishi H et al. | [Involvement of Fyn tyrosine kinase and membrane rafts in the signal transduction in Ca2+-sensitization of vascular smooth muscle contraction]. | 2007 | Nippon Yakurigaku Zasshi | pmid:17435334 |
sphingosine
sphingosine is a lipid of Sphingolipids (SP) class.
Cross Reference
